Cargando…

Metastatic neuroendocrine carcinoma presenting as multifocal liver lesions with elevated alpha‐fetoprotein

Significant elevations in alpha‐fetoprotein should raise suspicion for hepatocellular carcinoma as malignancies with metastasis to the liver can elevate the alpha‐fetoprotein level but typically <300 ng/mL. Diagnosis should be confirmed with typical characteristics of hepatocellular carcinoma on...

Descripción completa

Detalles Bibliográficos
Autores principales: Sobotka, Lindsay A., Hake, Timothy, Kelly, Crystal, Mousa, Luay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389483/
https://www.ncbi.nlm.nih.gov/pubmed/30847183
http://dx.doi.org/10.1002/ccr3.1956
_version_ 1783397944273141760
author Sobotka, Lindsay A.
Hake, Timothy
Kelly, Crystal
Mousa, Luay
author_facet Sobotka, Lindsay A.
Hake, Timothy
Kelly, Crystal
Mousa, Luay
author_sort Sobotka, Lindsay A.
collection PubMed
description Significant elevations in alpha‐fetoprotein should raise suspicion for hepatocellular carcinoma as malignancies with metastasis to the liver can elevate the alpha‐fetoprotein level but typically <300 ng/mL. Diagnosis should be confirmed with typical characteristics of hepatocellular carcinoma on imaging and or liver biopsy to confirm diagnosis.
format Online
Article
Text
id pubmed-6389483
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-63894832019-03-07 Metastatic neuroendocrine carcinoma presenting as multifocal liver lesions with elevated alpha‐fetoprotein Sobotka, Lindsay A. Hake, Timothy Kelly, Crystal Mousa, Luay Clin Case Rep Case Reports Significant elevations in alpha‐fetoprotein should raise suspicion for hepatocellular carcinoma as malignancies with metastasis to the liver can elevate the alpha‐fetoprotein level but typically <300 ng/mL. Diagnosis should be confirmed with typical characteristics of hepatocellular carcinoma on imaging and or liver biopsy to confirm diagnosis. John Wiley and Sons Inc. 2018-12-16 /pmc/articles/PMC6389483/ /pubmed/30847183 http://dx.doi.org/10.1002/ccr3.1956 Text en © 2018 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Sobotka, Lindsay A.
Hake, Timothy
Kelly, Crystal
Mousa, Luay
Metastatic neuroendocrine carcinoma presenting as multifocal liver lesions with elevated alpha‐fetoprotein
title Metastatic neuroendocrine carcinoma presenting as multifocal liver lesions with elevated alpha‐fetoprotein
title_full Metastatic neuroendocrine carcinoma presenting as multifocal liver lesions with elevated alpha‐fetoprotein
title_fullStr Metastatic neuroendocrine carcinoma presenting as multifocal liver lesions with elevated alpha‐fetoprotein
title_full_unstemmed Metastatic neuroendocrine carcinoma presenting as multifocal liver lesions with elevated alpha‐fetoprotein
title_short Metastatic neuroendocrine carcinoma presenting as multifocal liver lesions with elevated alpha‐fetoprotein
title_sort metastatic neuroendocrine carcinoma presenting as multifocal liver lesions with elevated alpha‐fetoprotein
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389483/
https://www.ncbi.nlm.nih.gov/pubmed/30847183
http://dx.doi.org/10.1002/ccr3.1956
work_keys_str_mv AT sobotkalindsaya metastaticneuroendocrinecarcinomapresentingasmultifocalliverlesionswithelevatedalphafetoprotein
AT haketimothy metastaticneuroendocrinecarcinomapresentingasmultifocalliverlesionswithelevatedalphafetoprotein
AT kellycrystal metastaticneuroendocrinecarcinomapresentingasmultifocalliverlesionswithelevatedalphafetoprotein
AT mousaluay metastaticneuroendocrinecarcinomapresentingasmultifocalliverlesionswithelevatedalphafetoprotein